Epicrispr Biotechnologies
Ultracompact therapies that modulate gene expression in vivo using CasMINI, the smallest known Cas protein.
Total raised
$177M
1 round on record
Last round
$177M
Aug 2026
Why it's on the radar
TeamFundraising signals (who's likely raising, and why) are on Team.Start a free 14-day trial →Funding history · 1 round
Aug 2026Form D$177MSEC filing
Key people
ProKey people, exec moves and open roles are on Pro.Start a free 14-day trial →